Background and aims：We have recently invented low-molecular-weight heparin/protamine micro/ nanoparticles (LH/P-MPs) as biodegradable carriers for adipose-derived stromal cells (ADSCs) that can be used for stem cell therapy to promote angiogenesis. LH/P-MPs bind to the cell surface of ADSCs and promote cell-to-cell interaction and aggregation of the ADSCs. When ADSC/LH/P-MP aggregates were cultured, LH/P-MPs maintained their viability. In this study, we examined the ability of these aggregates to rescue limb loss in a mouse model of hindlimb ischemia.
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Methods：Unilateral hindlimb ischemia was induced by ligation of the iliac artery and hindlimb vein of BALB/c mice. For allotransplantation of ADSCs from the same inbred strain, we injected ADSC alone or ADSC/LH/P-MP aggregates or control medium (sham-treated) into the sites of ischemic muscles. Ischemic limb blood perfusion, vessel density and vessel area were observed and the degree of ischemic limb necrosis or limb loss was assessed on post-operative days 2, 7 and 14.
Results：Compared with the sham-treatment, the treatment with ADSCs alone showed modest effects on blood perfusion recovery and increased number of a -SMA-positive vessels. These effects were significantly stronger following treatment with ADSC/ LH/P-MP aggregates compared with ADSCs by themselves. Consequently, the ADSC/LH/P-MP aggregates were more effective in preventing the loss of ischemic hindlimbs compared with ADSCs alone or the sham-treatment.
Conclusion：The LH/P-MPs augmented the effect of ADSCs on angiogenesis and the reversal of limb ischemia. Use of ADSC/LH/P-MP aggregates offers a novel and convenient treatment method, potentially representing a promising new therapeutic approach for inducing angiogenesis in ischemic diseases. 
